The growing Bienta currently employs 18 FTEs and is capable of performing HTS with a broad variety of biochemical and cell-based assays… (more…)

The main purpose of the Screening Group is to provide hit identification and hit-to-lead optimization contract services to the biotech and pharmaceutical industry. We are also open to discuss shared-risk exploratory hit finding projects with the industry or academic partners… (more…)

Our Molecular Modeling Group provides cheminformatics, molecular modeling, virtual screening and computational biology service saiming to accelerate hit identification, lead generation and lead optimization stages of the drug discovery process… (more…)

Integration of our powerful resources, comprehensive cheminformatics, molecular modeling, and computational biology expertise, with the deep knowledge and creativity in medicinal chemistry enables broad opportunities for fast-paced early-stage drug discovery projects… (more…)